Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
NORTHWEST BIO
(NQ:
NWBO
)
3.710
USD
+0.070 (+1.92%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
3.700
Bid (Size)
3.690 (2400)
Ask (Size)
3.700 (100)
Prev. Close
3.640
Today's Range
3.650 - 3.800
52wk Range
2.979 - 4.640
Shares Outstanding
27,140,417
Dividend Yield
N/A
Top News
More News
Northwest Bio (NWBO) Initiates P3 DCVax®-L Brain Cancer Trial
May 16, 2013
King’s College Hospital, UK Is 1st Site of 30 EU Sites to join 46 active sites in US NWBO P3 clinical trial with DCVax^®-L for brain cancer has been initiated at King’s College Hospital in the UK....
Read More
category
Henry McCusker
from
Bio-Wire.Com
NW Bio Initiates Phase III DCVax®-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open
May 16, 2013
Up To 30 European Sites To Join 46 Active Sites In The US
Read More
from
PR Newswire
More News
Read More
Interviews Of NW Bio's CEO, On The Floor Of The New York Stock Exchange, Now Available Online
May 03, 2013
from
PR Newswire
Mentor Capital Cancer Immunotherapy Index Gains 28% During First Quarter of 2013
May 02, 2013
from
Business Wire News Releases
RedChip Emerging Growth Showcase Takes Place May 1
April 23, 2013
from
GlobeNewswire News Releases
Indigestion waxes…enthusiasm wanes
April 18, 2013
category
Henry McCusker
from
Bio-Wire.Com
Northwest Bio (NWBO) Registered Direct Offering – SELL on financing news
April 18, 2013
category
Henry McCusker
from
Bio-Wire.Com
NW Bio Announces That Another Brain Cancer Patient From Phase I/II DCVax®-L Trials Has Surpassed Ten-Year Cancer-Free Survival
April 18, 2013
from
PR Newswire
NW Bio Announces $10 Million Registered Direct Offering
April 18, 2013
from
PR Newswire
NW Biotherapeutics (NWBO) Announces Adoption of its Phase III Trial as National Priority Trial in UK
April 17, 2013
from
PRBuzz Press Release Distribution
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here